Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice

Hepatology

Volumn 40, Issue 6, 2004, Pages 1322-1332

  Shteyer, Eyal ^a   Liao, Yunjun ^a   Muglia, Louis J ^a   Hruz, Paul W ^a   Rudnick, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LEPTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; EVALUATION; GENE EXPRESSION; HYPOTHESIS; LIPID STORAGE; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MALE; MORPHOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEATOSIS; UNINDEXED SEQUENCE; UPREGULATION; WILD TYPE;

ANIMALS; CELL DIVISION; FATS; HEPATECTOMY; HEPATOCYTES; LEPTIN; LIVER; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, GLUCOCORTICOID;

EID: 10644248333     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20462     Document Type: Article

References (49)

1. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
2. Diehl AM, Rai R. Liver regeneration. In: Schiff R, Sorrell MF, Maddrey WC, eds. Schiffs Diseases of the Liver. Philadelphia, PA: Lippincott-Raven, 1999:39-54.
3. Fausto N. Liver regeneration. J Hepatol 2000;32(1 Suppl):19-31.
4. Higgins GM, Anderson RM. Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
5. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263(4 Pt 1):G579-G585.
6. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
7. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
8. Lee FY, Li Y, Zhu H, Yang S, Lin HZ, Trush M, et al. Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. HEPATOLOGY 1999;29:677-687.
9. Rudnick DA, Perlmutter DH, Muglia LJ. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 2001;98:8885-8890.
10. Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, et al. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003-6011.
11. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994;269:30429-30435.
12. Cressman DE, Diamond RH, Taub R. Rapid activation of the STAT3 transcription complex in liver regeneration. HEPATOLOGY 1995;21:1443-1449.
13. Taub R. Liver regeneration .4. Transcriptional control of liver regeneration. FASEB J 1996;10:413-427.
14. MacKay EM, Carne HO. Influence of adrenalectomy and choline on the fat content of regenerating liver during fasting. Proc Soc Exp Biol Med 1938;38:131-133.
15. Delahunty TJ, Rubinstein D. Accumulation and release of triglycerides by rat liver following partial hepatectomy. J Lipid Res 1970;11:536-543.
16. Murray AB, Strecker W, Silz S. Ultrastructural changes in rat hepatocytes after partial hepatectomy, and comparison with biochemical results. J Cell Sci 1981;50:433-448.
17. Brewer JA, Khor B, Vogt SK, Muglia LM, Fujiwara H, Haegele KE, et al. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat Med 2003;9:1318-1322.
18. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-315.
19. Liang CP, Tall AR. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 2001;276: 49066-49076.
20. Haber BA, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993;91:1319-1326.
21. Folch J, Lees JM, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226:497-509.
22. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma 1 (PPAR-gamma1) overexpression. J Biol Chem 2003;278:498-505.
23. Wu Z, Xie Y, Bucher NL, Farmer SR. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 1995;9:2350-2363.
24. Danesch U, Hoeck W, Ringold GM. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem 1992;267:7185-7193.
25. Moustaid N, Lasnier F, Hainque B, Quignard-Boulange A, Pairault J. Analysis of gene expression during adipogenesis in 3T3-F442A preadipocytes: insulin and dexamethasone control. J Cell Biochem 1990;42:243-254.
26. Toscani A, Soprano DR, Soprano KJ. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J Biol Chem 1990;265:5722-5730.
27. Wolins NE, Skinner JR, Schoenfish MJ, Tzekov A, Bensch KG, Bickel PE. Adipocyte protein S3-12 coats nascent lipid droplets. J Biol Chem 2003; 278:37713-37721.
28. Diehl AM. Animal models of hepatic steatosis. Semin Liver Dis 2001;21: 89-104.
29. Ringold GM, Chapman AB, Knight DM, Torti FM. Hormonal control of adipogenesis. Ann N Y Acad Sci 1986;478:109-119.
30. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9:168-181.
31. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851-857.
32. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-1621.
33. Brewer JA, Kanagawa O, Sleckman BP, Muglia LJ. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol 2002;169:1837-1843.
34. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, et al. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998;102: 996-1007.
35. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis [review]. Genes Dev 2000;14:1293-1307.
36. Hamm JK, Park BH, Farmer SR. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem 2001;276:18464-18471.
37. Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 1982;42:4673-4682.
38. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994;91:6379-6383.
39. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-208.
40. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A 2000;97:3450-3454.
41. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 2003;63:132-139.
42. Knowles LM, Axelrod F, Browne CD, Smith JW. A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2. J Biol Chem 2004;279:30540-30545.
43. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 2004;91: 47-53.
44. Agostini M, Silva SD, Zecchin KG, Coletta RD, Jorge J, Loda M, et al. Fatty acid synthase is required for the proliferation of human oral squamous cancer cells. Oral Oncol 2004;40:728-735.
45. Qiao S, Pennanen P, Nazarova N, Lou YR, Tuohimaa P. Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J Steroid Biochem Mol Biol 2003;85:1-8.
46. Leclercq IA, Field J, Farrell GC. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 2003; 124:1451-1464.
47. Nagy P, Kiss A, Schnur J, Thorgeirsson SS. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. HEPATOLOGY 1998;28:423-429.
48. Grewe M, Gausling R, Gyufko K, Hoffmann R, Decker K. Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages. J Hepatol 1994;20:811-818.
49. Yang S, Koteish A, Lin H, Huang J, Roskams T, Dawson V, et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. HEPATOLOGY 2004;39:403-411.